Published in Gene Therapy Weekly, October 19th, 1998
Now available under the U.S. Food and Drug Administration (FDA)-regulated class, Analyte Specific Reagent (ASR), the MultiVysion PB reagent may help increase the success of in vitro fertilization (IVF) by avoiding the implantation of embryos that contain an abnormal number of a specific chromosome, a condition known as aneuploidy.
The announcement was made at the 54th Annual Meeting of the American...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.